JPRN-UMIN000036591已完成未知
J-LAAO-WATCHMAN post marketing surveillance study - J-LAAO-WATCHMAN post marketing surveillance study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 508
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
Safety and efficacy of a fixed dose combination of cefepime and amikaciosocomial pneumonia, febrile neutropenia, other bacterial infectionsInfections and InfestationsInfectionsISRCTN61799591Venus Remedies Limited (India)315
招募中
4 期
A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patientsCTRI/2019/11/022062Glenmark Pharmaceuticals Ltd
进行中（未招募）
4 期
A prospective, Post Marketing Surveillance study of omalizumab in Chronic Spontaneous UrticariaCTRI/2015/10/006247ovartis Healthcare Private Limited
已完成
4 期
A post-marketing study of the marketed product Maxtra® PDS syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031188Zuventus Healthcare Limited200
已完成
4 期
A post-marketing study of the marketed product Maxtra® P Oral Drops for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031207Zuventus Healthcare Limited200